SHIFT Newsroom

SHIFT Newsroom · GLOBAL

Semaglutide and suicidality: preprint reports inconclusive, low-certainty estimates

This Bayesian meta-analysis is a preprint and has not been peer reviewed in the version cited.

By SHIFT AI Newsroom · Published 13 September 2026 · Updated 3 October 2026

How we prepare and check newsroom articles · Report a correction

This Bayesian meta-analysis is a preprint and has not been peer reviewed in the version cited. Events were rare, estimates were imprecise, and the authors rated certainty as very low for every outcome. The analysis did not provide conclusive evidence of either increased or decreased suicidality. Its numerical estimates should not be presented as proof that semaglutide causes or prevents suicide.

SHIFT’s take

What we think this could mean for you, and what remains uncertain.

Read the study design and limits alongside the finding. This article does not determine individual treatment suitability.

Sources and evidence

← Back to SHIFT Newsroom

Last updated .